Abstract
The incidence of clinically significant, nonfunctioning pituitary adenoma, requiring surgical treatment, has not been established. According to previous studies, both surgery type and subsequent radiotherapy may have an impact on quality of life (QOL), and some studies have shown increased cardiovascular mortality in patients with pituitary disease. We studied all patients with functionless, suprasellar pituitary adenoma who were operated on during the period 1985–1996 (N = 192; transsphenoidal surgery = 160, craniotomy = 32). QOL was evaluated from Short Form 36 and Major Depression Inventory questionnaires. Causes of death were obtained from the Danish Register of Causes of Death. Incidence was 5.6/mill/year. Postoperatively, 27% of the patients had normal pituitary function and 27% were panhypopituitary. Fifty three patients had died. Death from cardiovascular, cerebrovascular and malignant diseases was not increased. Overall, QOL was not different from QOL of an age- and sex matched background population. QOL was, however, impaired in patients who had undergone craniotomy as compared to patients undergoing transsphenoidal surgery. QOL was not reduced in hypopituitary patients or in patients receiving radiotherapy.
Similar content being viewed by others
References
Ezzat S, Asa SL., Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas. Cancer 101:613–619
Page RCL, Hammersley MS, Burke CW, Wass JAH (1997) An account of the quality of life of patients after treatment for non-functioning pituitary tumours. Clin Endocrinol 46:401–406
Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with a pituitary adenoma. Pituitary 6:81–87
Peace KA, Orme SM, Sebastian JP, Thompson AR, Barnes S, Ellis A, Belchet PE (1997) The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease. Clin Endocrinol 46:445–450
Dekkers OM, van der Klaauw AA, Pereira AM, Biermasz NR, Honkoop PJ, Roelfsema F, Smit JWA, Romijn JA (2006) Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metabol 91:3364–3369
Rosen T, Bengtsson B-A (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285–288
Bates AS, Van’t Hoff W, Jones PJ, Clayton RN (1996) The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metabol 81:1169–1172
Bülow B, Hagmar L, Mikoczy Z, Nordström CH, Erfurth EM (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 46:75–81
Bates AS, Bullivant B, Sheppard MC, Stewart PM (1999) Life expectancy following surgery for pituitary tumours. Clin Endocrinol 50:315–319
Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM and the West Midlands Prospective Hypopituitary Study Group (2001) Association between premature mortality and hypopituitarism. Lancet 357:425–431
Svensson J, Bengtsson B-A, Rosen T, Oden A, Johansson G (2004) Malignant disease and cardiovascular morbidity in hypopituitary adults with and without growth hormone replacement therapy. J Clin Endocrinol Metabol 89:3306–3312
Nilsson B, Gustavsson-Kadaka E, Bengtsson B-A, Jonsson B (2000) Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival and mortality. J Clin Endocrinol Metabol 85:1420–1425
Lindholm J, Nielsen EH, Bjerre P, Christiansen JS, Hagen C, Juul S, Jørgensen J, Kruse A, Laurberg P, Stochholm K (2006) Hypopituitarism and mortality in pituitary adenoma. Clin Endocrinol 65:51–59
Nielsen EH, Lindholm J, Bjerre P, Christiansen JS, Hagen C, Juul S, Jørgensen J, Kruse A, Laurberg P (2006) Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma. Clin Endocrinol 64:319–322
Bjørner JB, Damsgaard MT, Watt T, Bech P, Rasmussen NK, Kristensen TS, Modvig J, Thunedborg K (1997) Danish SF-36 Manual Copenhagen, LIF
Bech P, Rasmussen NA, Olsen LR, Nørholm V, Abildgaard W (2001) The sensitivity and specificity of the major depression inventory, using the present state examination as the index of diagnostic validity. J Affect Disord 66:159–164
Statistical Yearbooks. Danmarks Statistik, Copenhagen
Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liège, Belgium. J Clin Endocrinol Metab 91:4769–4775
Barahona MJ, Sojo L, Wagner AM, Bartumeus F, Oliver B, Cano P, Webb SM (2005) Determinants of neurosurgical outcome in pituitary adenomas. J Endocrinol Invest 28:787–794
Brada M, Ashley S, Ford D, Traish D, Burchell L, Rajan B (2002) Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol 57:713–717
Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML for The Endocrine Society’s Clinical Guidelines Subcommittee. (2006) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol 91:1621–1634
Oliveira JLM, Marques-Santos C, Barreto-Filho JA, Filho RX, de Oliveira Britto AV, Souza AHO, Prado CM, Oliveira CRP, Pereira RMC, de Almeida Ribeiro Vicente T, Farias CT, Aguiar-Oliveira MH, Salvatori R (2006) Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation. J Clin Endocrinol Metabol 91:2093–2099
Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ (2005) Quality of life (QoL) in patients with acromegaly is severely impaired: use of a novel measure of QoL: acromegaly quality of life questionnaire. J Clin Endocrinol Metabol 90:3337–3341
Trepp R, Everts R, Stettler C, Fischli S, Allemann S, Webb SM, Christ ER (2005) Assessment of quality of life in patients with uncontrolled versus controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL). Clin Endocrinol 63:103–110
Lindholm J, Juul S, Jørgensen JOL, Astrup J, Bjerre P, Hagen C, Jørgensen J, Kosteljanetz M, Kristensen LØ, Laurberg P, Feldt-Rasmussen U, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing’s syndrome, a population based study. J Clin Endocrinol Metabol 86:117–123
van Aken MO, Pereira AM, Biermasz NR, van Thiel SW., Hoftijzer HC, Smit JWA, Roelfsema F, Lamberts SWJ, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing’s disease. J Clin Endocrinol Metabol 90:3279–3286
Author information
Authors and Affiliations
Corresponding author
Additional information
The study was supported by grants from The Aarhus University Hospital Research Initiative and The Obel Family Foundation, Aalborg, Denmark
Rights and permissions
About this article
Cite this article
Nielsen, E.H., Lindholm, J., Laurberg, P. et al. Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function. Pituitary 10, 67–73 (2007). https://doi.org/10.1007/s11102-007-0018-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-007-0018-x